NASDAQ:AGIO - Agios Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$62.43 +0.14 (+0.22 %)
(As of 03/25/2019 01:42 PM ET)
Previous Close$62.29
Today's Range$61.18 - $62.70
52-Week Range$41.63 - $99.82
Volume8,163 shs
Average Volume470,579 shs
Market Capitalization$3.65 billion
P/E Ratio-10.35
Dividend YieldN/A

Analyst Ratings

Agios Pharmaceuticals (NASDAQ:AGIO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Agios Pharmaceuticals in the last 12 months. Their average twelve-month price target is $97.8571, suggesting that the stock has a possible upside of 56.75%. The high price target for AGIO is $123.00 and the low price target for AGIO is $80.00. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.822.822.692.67
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $97.8571$97.8571$97.50$97.50
Price Target Upside: 56.75% upside70.53% upside39.29% upside29.12% upside

Agios Pharmaceuticals (NASDAQ:AGIO) Consensus Price Target History

Price Target History for Agios Pharmaceuticals (NASDAQ:AGIO)

Agios Pharmaceuticals (NASDAQ:AGIO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/13/2019CowenReiterated RatingBuyHighView Rating Details
2/20/2019OppenheimerReiterated RatingMarket PerformLowView Rating Details
2/15/2019Svb LeerinkUpgradeMarket Perform ➝ Outperform$80.00HighView Rating Details
2/15/2019Leerink SwannUpgradeMarket Perform ➝ OutperformHighView Rating Details
2/14/2019Piper Jaffray CompaniesLower Price TargetOverweight$100.00HighView Rating Details
9/17/2018GuggenheimInitiated CoverageNeutralLowView Rating Details
9/5/2018Canaccord GenuityReiterated RatingBuy$90.00HighView Rating Details
8/2/2018Needham & Company LLCReiterated RatingBuyHighView Rating Details
7/23/2018SunTrust BanksReiterated RatingBuy$123.00LowView Rating Details
5/23/2018CitigroupInitiated CoverageBuy$117.00HighView Rating Details
5/7/2018Credit Suisse GroupSet Price TargetBuy$95.00LowView Rating Details
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$76.00 ➝ $85.00LowView Rating Details
2/14/2018UBS GroupDowngradeOutperform ➝ Market PerformLowView Rating Details
1/18/2018Royal Bank of CanadaBoost Price TargetOutperform$91.00MediumView Rating Details
8/1/2017Janney Montgomery ScottReiterated RatingHoldHighView Rating Details
(Data available from 3/25/2017 forward)
This page was last updated on 3/25/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel